Nebulisation in childhood asthma

被引:1
作者
Siret, D
Luc, C
Dubus, JC [1 ]
机构
[1] CHU Timone, Unite Med Infantile, F-13385 Marseille, France
[2] CHU Timone, EA3287, F-13385 Marseille, France
[3] Ctr Hosp St Nazaire, Serv Pediat, F-44606 St Nazaire, France
来源
ARCHIVES DE PEDIATRIE | 2005年 / 12卷
关键词
asthma; drug administration; inhalation; child;
D O I
10.1016/S0929-693X(05)80031-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The inhaled route way, which directly brings an appropriate amount of drug in the right place, is at the present time the recommended route for asthma treatments. The development of spacer devices, easier to use, has reduced the indications of nebulised treatments, but these are still essential in some situations. Nebulisation of short acting beta-2-agonists, which usually requires oxygen administration, is still the first line treatment of a severe acute asthma attack. Ipratropium bromure can be added in the nebulisation, depending on the severity of the attack and the response to beta-2-agonists. Sodium cromoglycate is not used in the prophylactic treatment of childhood asthma any more, but nebulised budesonide is still very useful in moderate to severe persistent asthma in children under 5 years of age, after failure of a treatment with a spacer device. The quality of nebulisation is fully dependent on the equipment used, and on the practical conditions of its realization. It is of most extreme importance to use a compressor/nebulizer couple which is validated for the delivered drug, and that the child breathes, depending on age, via a mouth peace or a facial mask. (c) 2005 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:S139 / S141
页数:3
相关论文
共 13 条
[1]   Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears! [J].
Amirav, I ;
Balanov, I ;
Gorenberg, M ;
Groshar, D ;
Luder, AS .
ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (08) :719-723
[2]  
CAMARGO CA, 2003, COCHRANE DATABASE SY
[3]  
CATES CJ, 2002, COCHRANE DB SYST REV, V2
[4]   Inhaled treatments delivery in children [J].
Dubus, JC .
ARCHIVES DE PEDIATRIE, 2003, 10 (12) :1083-1088
[5]  
Dubus JC, 2002, ARCH PEDIATRIE, V9, p384S
[6]  
*GRAPP, 2003, IN PRESS REV MAL RES
[7]  
L'her E, 2002, Rev Mal Respir, V19, P658
[8]  
MARGUET C, 2004, ENSEIGNEMENTS SUPERI, P459
[9]  
*NAEPP, 2002, J ALLERGY CLIN IMMUN, V110, P141
[10]  
PLOTNICK LH, 2000, COMBINED INHALED ANT